Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001410578-25-001047
Filing Date
2025-04-30
Accepted
2025-04-30 16:05:54
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A eyen-20241231x10ka.htm   iXBRL 10-K/A 710534
2 EX-31.2 eyen-20241231xex31d2.htm EX-31.2 5586
  Complete submission text file 0001410578-25-001047.txt   1056336

Data Files

Seq Description Document Type Size
3 EX-101.SCH eyen-20241231.xsd EX-101.SCH 3660
4 EX-101.LAB eyen-20241231_lab.xml EX-101.LAB 25136
5 EX-101.PRE eyen-20241231_pre.xml EX-101.PRE 16514
19 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20241231x10ka_htm.xml XML 12247
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38365 | Film No.: 25894955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)